Incidental adrenal masses are common—estimated to occur in approximately 3–7% of adults.

How many patients with incidental adrenal mass lesions passed undetected through your institution last year?

Dale’s Routine Abdominal

57-year-old male presented for routine abdominal CT, a 2.1 cm left adrenal nodule was noted. Our software identified the patient. The nurse navigator investigated further and saw the patient had an abdominal CT 3 years ago that did not describe an adrenal nodule. The nurse was able to contact the patients PCP to bring him back in for lab work and appropriate subsequent follow up.

Patient and Provider Value

Managing a population of patients with adrenal nodules is especially challenging as most people are unaware, they have adrenal glands. Discovery360 enables nurse navigators to teach patients about the adrenal gland and their incidental nodule finding.

The overwhelming response is one of gratitude and relief knowing someone cares about them enough to invest in technology to identify such a finding so treatment options can be improved.

Likewise, a PCP can immediately see the value in notifying patients of the incidental finding and providing the appropriate and timely treatment.

Discovery360 Key Benefits:

Illuminate helps integrated care organizations:
  • Improve Patient Outcomes with Targeted and Rapid Follow-up
  • Understand and Manage Progress Towards Organizational Improvement
  • Increase Revenue from Incremental Imaging, Testing, and Surgery
  • Reduce Medico-Legal Risk
Discovery360 is a multi-phase workflow solution that powers the identification, follow-up, and coordination of treatment for at-risk patients.

While the most frequent type of incidental adrenal mass is a benign, nonhyperfunctioning adenoma, the adrenal gland is also a common site of metastases. Less commonly adrenal masses can be primary adrenal tumors including pheochromocytomas, aldosteronomas, and adrenal cortical carcinomas.

Benefits Across the Healthcare Organization

Benefits Across the Healthcare Organization

“As a clinician, I notice incidental adrenal nodules on many radiology reports but no recommendation for specific follow-up or if follow is even needed. An incidental adrenal nodule follow-up protocol to make sure my patients are evaluated properly would enhance my patients well being and improve my patients' outcomes.”

Mark Perry, MD

Associate Professor of Radiology at KUMC and Section Head of Oncologic Imaging


  • Identify patients with early-stage, treatable cancer to improve their clinical outcome
  • We can help shorten the time for a patient to receive a diagnosis and treatment


  • Reinforce their role in both diagnosing and capturing incidental findings and ensuring follow-up imaging is performed


  • Streamlines and simplifies referrals to specialist.
  • Integrates into current state workflow to support efficiency for providers.


  • Increased downstream revenue from oncology, surgery, and radiation oncology


Further establish your hospital as being:

  • Proactive in maximizing patient care
  • Mitigating medical legal risk
  • Eliminating potential professional liability claims from missed diagnoses

Put the Illuminate Clinical Team to Work for You